-
1
-
-
33845974147
-
Valvular heart disease and the use of dopamine agonists for Parkinson's disease
-
Zanettini, R., Antonini, A., Gatto, G. et al. (2007) Valvular heart disease and the use of dopamine agonists for Parkinson's disease. New England Journal of Medicine, 356, 39-46. (Pubitemid 46041752)
-
(2007)
New England Journal of Medicine
, vol.356
, Issue.1
, pp. 39-46
-
-
Zanettini, R.1
Antonini, A.2
Gatto, G.3
Gentile, R.4
Tesei, S.5
Pezzoli, G.6
-
2
-
-
79955672955
-
Regression of cardiac valvulopathy related to ergot-derived dopamine agonists
-
Zanettini, R., Antonini, A., Gatto, G. et al. (2011) Regression of cardiac valvulopathy related to ergot-derived dopamine agonists. Cardiovascular Therapy, 29, 404-410.
-
(2011)
Cardiovascular Therapy
, vol.29
, pp. 404-410
-
-
Zanettini, R.1
Antonini, A.2
Gatto, G.3
-
3
-
-
54049134741
-
Cabergoline and cardiac valve disease in prolactinoma patients: Additional studies during long-term treatment are required
-
Kars, M., Pereira, A.M., Bax, J.J. et al. (2008) Cabergoline and cardiac valve disease in prolactinoma patients: additional studies during long-term treatment are required. European Journal of Endocrinology, 159, 363-367.
-
(2008)
European Journal of Endocrinology
, vol.159
, pp. 363-367
-
-
Kars, M.1
Pereira, A.M.2
Bax, J.J.3
-
4
-
-
0033039361
-
Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (The Framingham Heart Study)
-
DOI 10.1016/S0002-9149(98)01064-9, PII S0002914998010649
-
Singh, J.P., Evans, J.C., Levy, D. et al. (1999) Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study). American Journal of Cardiology, 83, 897-902. (Pubitemid 29143128)
-
(1999)
American Journal of Cardiology
, vol.83
, Issue.6
, pp. 897-902
-
-
Singh, J.P.1
Evans, J.C.2
Levy, D.3
Larson, M.G.4
Freed, L.A.5
Fuller, D.L.6
Lehman, B.7
Benjamin, E.J.8
-
5
-
-
51649119890
-
Aortic valve calcification and mild tricuspid regurgitation but no clinical heart disease after 8 years of dopamine agonist therapy for prolactinoma
-
Kars, M., Delgado, V., Holman, E.R. et al. (2008) Aortic valve calcification and mild tricuspid regurgitation but no clinical heart disease after 8 years of dopamine agonist therapy for prolactinoma. Journal of Clinical Endocrinology and Metabolism, 93, 3348-3356.
-
(2008)
Journal of Clinical Endocrinology and Metabolism
, vol.93
, pp. 3348-3356
-
-
Kars, M.1
Delgado, V.2
Holman, E.R.3
-
6
-
-
0022588019
-
Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings
-
DOI 10.1016/0002-9149(86)90771-X
-
Devereux, R.B., Alonso, D.R., Lutas, E.M. et al. (1986) Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. American Journal of Cardiology, 57, 450-458. (Pubitemid 16119719)
-
(1986)
American Journal of Cardiology
, vol.57
, Issue.6
, pp. 450-458
-
-
Devereux, R.B.1
Alonso, D.R.2
Lutas, E.M.3
-
7
-
-
33747116680
-
ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients with Valvular Heart Disease) - Developed in collaboration with the Society of Cardiovascular Anesthesiologists
-
DOI 10.1161/CIRCULATIONAHA.106.176857, PII 0000301720060801000024
-
Bonow, R.O., Carabello, B.A., Kanu, C. et al. (2006) ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation, 114, e84-e231. (Pubitemid 44268973)
-
(2006)
Circulation
, vol.114
, Issue.5
-
-
Bonow, R.O.1
Carabello, B.A.2
Chatterjee, K.3
De Leon Jr., A.C.4
Faxon, D.P.5
Freed, M.D.6
Gaasch, W.H.7
Lytle, B.W.8
Nishimura, R.A.9
O'Gara, P.T.10
O'Rourke, R.A.11
Otto, C.M.12
Shah, P.M.13
Shanewise, J.S.14
-
8
-
-
33847134400
-
Guidelines on the management of valvular heart disease: The task force on the management of valvular heart disease of the European society of cardiology
-
DOI 10.1093/eurheartj/ehl428
-
Vahanian, A., Baumgartner, H., Bax, J. et al. (2007) Guidelines on the management of valvular heart disease: the Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. European Heart Journal, 28, 230-268. (Pubitemid 46276943)
-
(2007)
European Heart Journal
, vol.28
, Issue.2
, pp. 230-268
-
-
Vahanian, A.1
Baumgartner, H.2
Bax, J.3
Butchart, E.4
Dion, R.5
Filippatos, G.6
Flachskampf, F.7
Hall, R.8
Lung, B.9
Kasprzak, J.10
Nataf, P.11
Tornos, P.12
Torracca, L.13
Wenink, A.14
-
9
-
-
0032505060
-
An assessment of heart-valve abnormalities in obese patients taking dexfenfluramine, sustained-release dexfenfluramine, or placebo
-
DOI 10.1056/NEJM199809103391103
-
Weissman, N.J., Tighe Jr, J.F., Gottdiener, J.S. et al. (1998) An assessment of heart-valve abnormalities in obese patients taking dexfenfluramine, sustained-release dexfenfluramine, or placebo. Sustained-Release Dexfenfluramine Study Group. New England Journal of Medicine, 339, 725-732. (Pubitemid 28417355)
-
(1998)
New England Journal of Medicine
, vol.339
, Issue.11
, pp. 725-732
-
-
Weissman, N.J.1
Tighe Jr., J.F.2
Gottdiener, J.S.3
Gwynne, J.T.4
-
10
-
-
33846017361
-
Drugs and valvular heart disease
-
Roth, B.L. (2007) Drugs and valvular heart disease. New England Journal of Medicine, 356, 6-9.
-
(2007)
New England Journal of Medicine
, vol.356
, pp. 6-9
-
-
Roth, B.L.1
-
11
-
-
77955719568
-
Assessment of cardiac valve dysfunction in patients receiving cabergoline treatment for hyperprolactinaemia
-
Tan, T., Cabrita, I.Z., Hensman, D. et al. (2010) Assessment of cardiac valve dysfunction in patients receiving cabergoline treatment for hyperprolactinaemia. Clinical Endocrinology (Oxford), 73, 369-374.
-
(2010)
Clinical Endocrinology (Oxford)
, vol.73
, pp. 369-374
-
-
Tan, T.1
Cabrita, I.Z.2
Hensman, D.3
-
12
-
-
77749234191
-
Potential cardiac valve effects of dopamine agonists in hyperprolactinemia
-
Valassi, E., Klibanski, A. & Biller, B.M. (2010) Potential cardiac valve effects of dopamine agonists in hyperprolactinemia. Journal of Clinical Endocrinology and Metabolism, 95, 1025-1033.
-
(2010)
Journal of Clinical Endocrinology and Metabolism
, vol.95
, pp. 1025-1033
-
-
Valassi, E.1
Klibanski, A.2
Biller, B.M.3
-
13
-
-
33847014811
-
Aortic valve calcification: Determinants and progression in the population
-
Messika-Zeitoun, D., Bielak, L.F., Peyser, P.A. et al. (2007) Aortic valve calcification: determinants and progression in the population. Arteriosclerosis, Thrombosis, and Vascular Biology, 27, 642-648.
-
(2007)
Arteriosclerosis, Thrombosis, and Vascular Biology
, vol.27
, pp. 642-648
-
-
Messika-Zeitoun, D.1
Bielak, L.F.2
Peyser, P.A.3
-
14
-
-
0035899912
-
Progression of aortic valve calcification: Association with coronary atherosclerosis and cardiovascular risk factors
-
Pohle, K., Maffert, R., Ropers, D. et al. (2001) Progression of aortic valve calcification: association with coronary atherosclerosis and cardiovascular risk factors. Circulation, 104, 1927-1932. (Pubitemid 32983236)
-
(2001)
Circulation
, vol.104
, Issue.16
, pp. 1927-1932
-
-
Pohle, K.1
Maffert, R.2
Ropers, D.3
Moshage, W.4
Stilianakis, N.5
Daniel, W.G.6
Achenbach, S.7
-
15
-
-
0029764784
-
Progression of valvular aortic stenosis in adults: Literature review and clinical implications
-
DOI 10.1016/S0002-8703(96)90440-8
-
Faggiano, P., Aurigemma, G.P., Rusconi, C. et al. (1996) Progression of valvular aortic stenosis in adults: literature review and clinical implications. American Heart Journal, 132, 408-417. (Pubitemid 26292409)
-
(1996)
American Heart Journal
, vol.132
, Issue.2 I
, pp. 408-417
-
-
Faggiano, P.1
Aurigemma, G.P.2
Rusconi, C.3
Gaasch, W.H.4
-
16
-
-
0027991976
-
Characterization of the early lesion of 'degenerative' valvular aortic stenosis: Histological and immunohistochemical studies
-
Otto, C.M., Kuusisto, J. & Reichenbach, D.D. (1994) Characterization of the early lesion of 'degenerative' valvular aortic stenosis. Histological and immunohistochemical studies. Circulation, 90, 844-853. (Pubitemid 24242754)
-
(1994)
Circulation
, vol.90
, Issue.2
, pp. 844-853
-
-
Otto, C.M.1
Kuusisto, J.2
Reichenbach, D.D.3
Gown, A.M.4
O'Brien, K.D.5
|